髄膜炎菌ワクチン：企業と競争環境...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 7
1.1 List of Tables 8
1.2 List of Figures 9
2 Introduction 10
2.1 Catalyst 10
2.2 Related Reports 11
2.3 Upcoming Related Reports 11
3 Market Outlook 12
3.1 Global Markets 12
3.1.1 Forecast 12
3.1.2 Drivers and Barriers – Global Issues 16
4 Current and Future Players 20
4.1 Overview 20
4.2 Trends in Corporate Strategy 24
4.3 Company Profiles 26
4.3.1 Sanofi 26
4.3.2 Novartis 30
4.3.3 GlaxoSmithKline 34
4.3.4 Baxter 37
4.3.5 Nuron Biotech 39
4.3.6 Pfizer 41
5 Appendix 43
5.1 Bibliography 43
5.2 Abbreviations 47
5.3 Methodology 49
5.4 Forecasting Methodology 49
5.4.1 Vaccine Coverage 50
5.4.2 Vaccine Approval vs. Routine Schedule Inclusion 50
5.4.3 Vaccines Included 51
5.4.4 Key Launch Dates 52
5.4.5 General Pricing Assumptions 53
5.4.6 Individual Vaccine Assumptions 54
5.4.7 Pricing of Pipeline agents 61
5.5 Physicians and Specialists Included in this Study 62
5.6 About the Authors 66
5.6.1 Author(s) 66
5.6.2 Reviewer(s) 66
5.6.3 Epidemiologist(s) 67
5.6.4 Global Head of Healthcare 68
5.7 About GlobalData 69
5.8 Disclaimer 69